Collector
Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial | Collector
Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
MarketWatch

Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial

The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.

Go to News Site
MarketWatch
Gold has tumbled during the Iran war — exposing a massive my
MarketWatch
Gold has tumbled during the Iran war — exposing a massive myth about geopolitical risk
 Gold just had its worst selloff since March. A floor may be
MarketWatch
Gold just had its worst selloff since March. A floor may be $4,000, says one veteran strategist
 Why tech’s record pullback is just a ‘healthy reset’ for the
MarketWatch
Why tech’s record pullback is just a ‘healthy reset’ for the bull market, according to Morgan Stanley’s top stock-market strategist
 My golf buddy worked as a financial adviser. Here’s how I re
MarketWatch
My golf buddy worked as a financial adviser. Here’s how I really knew his friendship was fake.
 Eli Lilly stock jumps after late-stage trial of next-generat
MarketWatch
Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
 What nine different indicators say about market exuberance,
MarketWatch
What nine different indicators say about market exuberance, according to Goldman Sachs
 ‘I have no experience with investing’: I inherited $2,000. I
MarketWatch
‘I have no experience with investing’: I inherited $2,000. I’m 42 with two children. What should I do with this money?
 Serena Williams is making a comeback; these are the properti
MarketWatch
Serena Williams is making a comeback; these are the properties that built her $35 million real estate portfolio
 Alanis Morissette quickly sells her Bay Area estate in lucra
MarketWatch
Alanis Morissette quickly sells her Bay Area estate in lucrative $9.6 million sale
 Nvidia strikes a new memory-chip deal — but SK Hynix and Sam
MarketWatch
Nvidia strikes a new memory-chip deal — but SK Hynix and Samsung shares are under heavy pressure
 Nvidia strikes a new memory-chip deal — but SK Hynix and Sam
MarketWatch
Nvidia strikes a new memory-chip deal — but SK Hynix and Samsung shares are under heavy pressure
 The Wegovy pill is still dominating the GLP-1 pill market
MarketWatch
The Wegovy pill is still dominating the GLP-1 pill market